Home > News > Antibodies, Inc. To Produce Quantum Dot Conjugates
April 1st, 2004
Antibodies, Inc. To Produce Quantum Dot Conjugates
Abstract:
Antibodies Incorporated, Davis, Calif., announced today that they are immediately commencing shipment of quantum dot-based secondary antibody, Streptavidin, Protein A and Protein G conjugates as well as launching a custom quantum dot conjugation service. Using EviTags® from Evident Technologies, Inc., these conjugates will be made ready-to-use for researchers in biology, life-sciences, drug discovery, disease diagnostics, proteomics, and genomics.
Source:
Antibodies, Inc. & Evident Technologies
Related News Press |
Nanomedicine
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Announcements
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||